Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-04-28 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Credit Rating
Regulatory Filings Classification · 95% confidence The document is an official communication from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding an upgrade in the company's credit rating by India Ratings and Research. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content includes detailed credit rating information, rationale, financial summaries, and rating sensitivities. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a simple announcement of a report publication. It is a regulatory disclosure about a credit rating update, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories such as Capital/Financing Update (CAP) or Interest Rate Update (IRAT). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-04-28 English
Intimation of Credit rating
Capital/Financing Update Classification · 95% confidence The document is an official communication from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding an upgrade in the company's credit rating by India Ratings and Research. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content includes detailed credit rating information, rationale for the rating upgrade, financial summaries, and rating sensitivities. The document is not a full financial report like an annual or interim report, nor is it a transcript, management report, or governance document. It is an update on the company's credit rating, which falls under capital/financing updates. The length (15,000 characters) and detailed financial and credit information support this classification. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2022-04-28 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the partial redemption of Non-Convertible Debentures (NCDs). It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides specific details about the redemption amount and date. The content is an update on a financing activity (debt redemption), not a full financial report or earnings release. The document length is short (1195 characters), and it is an announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-04-22 English
Redemption
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the partial redemption of Non-Convertible Debentures (NCDs). It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides specific details about the redemption amount and date. The content is an update on a financing activity (redemption of debt securities), not a full financial report or earnings release. The document length is short (1195 characters), and it is an announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-04-22 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Capital/Financing Update Classification · 95% confidence The document is an initial disclosure and details of incremental borrowings made by Torrent Pharmaceuticals Limited, identified as a Large Corporate under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26-Nov-18. It includes specific financial data related to borrowings, credit ratings, and compliance with mandatory borrowing through debt securities for the fiscal year 2021-22. The document is addressed to stock exchanges and includes detailed tables of borrowing amounts and penalties, indicating it is a regulatory disclosure related to financing activities. It is not a full annual or interim report, nor an earnings release or management discussion. The content aligns with updates on company fundraising and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7249 characters) and detailed financial data support this classification with high confidence.
2022-04-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is an initial disclosure and details of incremental borrowings made by Torrent Pharmaceuticals Limited, identified as a Large Corporate under SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26-Nov-18. It includes specific financial data related to borrowings, credit ratings, and compliance with mandatory borrowing through debt securities for the fiscal year 2021-22. The document is addressed to stock exchanges and is a regulatory compliance disclosure rather than a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion but focuses on borrowing disclosures as required by a regulatory circular. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-04-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.